Green Builder Media Announces Annual Readers Choice Awards
/
Date01 May 2019
Email Print Friendly Share Lake City, Colo., May 01, 2019 (GLOBE NEWSWIRE) — Green Builder Media announces the publication of its 2019 green brand survey.... Read More →
West High Yield Announces Technical Report
/
Date01 May 2019
Email Print Friendly Share CALGARY, Alberta, May 01, 2019 (GLOBE NEWSWIRE) — West High Yield (W.H.Y.) Resources Ltd. (the “Company”) (TSXV: WHY) is pleased to... Read More →
Brink’s Declares Quarterly Dividend
/
Date01 May 2019
Email Print Friendly Share RICHMOND, Va., May 01, 2019 (GLOBE NEWSWIRE) — The board of directors of The Brink’s Company (NYSE:BCO) today declared a regular... Read More →
Parkland Fuel Corporation Announces Record 2019 First Quarter Results
/
Date01 May 2019
Email Print Friendly Share CALGARY, Alberta, May 01, 2019 (GLOBE NEWSWIRE) — Parkland Fuel Corporation, (“Parkland”, “We”, the “Company”, or “Our”) (TSX:PKI) announced today the... Read More →
Allied Announces Acquisitions in Toronto, Calgary and Vancouver
/
Date01 May 2019
Email Print Friendly Share TORONTO, May 01, 2019 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX:AP.UN) announced today that it has acquired... Read More →
Veloxis to Host Conference Call Following Release of Interim Financial Report for the Period 1 January to 31 March 2019
/
Date01 May 2019
Email Print Friendly Share Investor News no. 02/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 1 May 2019 Veloxis to Host Conference... Read More →
SAG announces the postponement of the disclosure of the FY 2018 Separated and Consolidated Accounts
/
Date01 May 2019
Email Print Friendly Share The announcement may be consulted in the following link: https://web3.cmvm.pt/sdi/emitentes/docs/PC71997.pdf
Biogen to Present New Interim Data from Its Phase 1/2 Clinical Study of Tofersen (BIIB067) for the Potential Treatment of a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS)
/
Date01 May 2019
Email Print Friendly Share Tofersen, an antisense oligonucleotide (ASO) that selectively targets the genetic driver of disease, is being studied for the potential treatment of... Read More →
Ninepoint Partners Completes Ninepoint 2019 Flow-Through Limited Partnership Initial Public Offering
/
Date01 May 2019
Email Print Friendly Share TORONTO, April 16, 2019 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint”) is pleased to announce that the Ninepoint 2019 Flow-Through Limited... Read More →